日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Successful management of denosumab discontinuation in a patient with primary pediatric osteoporosis

成功管理原发性儿童骨质疏松症患者停用地诺单抗

Anastasilakis, Athanasios D; Makras, Polyzois; Polyzos, Stergios A; Yavropoulou, Maria P; Papapoulos, Socrates E

Bisphosphonates in the Management of Patients with Postmenopausal Osteoporosis; Back to the Future

双膦酸盐在绝经后骨质疏松症患者治疗中的应用;回到未来

Papapoulos, Socrates E; Makras, Polyzois

Long-term clinical and bone mineral density changes of adult patients with sclerostin deficiency due to van Buchem disease: a follow-up study

范布赫姆病引起的硬骨蛋白缺乏症成年患者的长期临床和骨矿物质密度变化:一项随访研究

Appelman-Dijkstra, Natasha M; Avci, Telli Merve; Schoeb, Manuela; Winter, Elizabeth M; van Lierop, Antoon; Papapoulos, Socrates E

Incidence of fractures in patients with solid cancers treated with immune checkpoint inhibitors: a systematic review and meta-analysis of randomised controlled trials

接受免疫检查点抑制剂治疗的实体瘤患者骨折发生率:随机对照试验的系统评价和荟萃分析

Yavropoulou, Maria P; Anastasilakis, Dimitrios A; Kasdagli, Maria-Iosifina; Gialouri, Chrysoula G; Palaiopanos, Konstantinos; Fountas, Athanasios; Anastasilakis, Athanasios D; Daskalakis, Kosmas; Dekkers, Olaf M; Lems, Willem F; Papapoulos, Socrates E; Makras, Polyzois

Cyclical Etidronate Reduces the Progression of Arterial Calcifications in Patients with Pseudoxanthoma Elasticum: A 6-Year Prospective Observational Study

周期性依替膦酸钠治疗可减缓假性黄色瘤患者动脉钙化的进展:一项为期6年的前瞻性观察研究

Harmsen, Iris M; van den Beukel, Tim; Kok, Madeleine; Visseren, Frank L J; de Jong, Pim A; Papapoulos, Socrates E; Spiering, Wilko

Similarities and Differences in the Management of Patients with Osteoporotic Vertebral Fractures and Those with Rebound-Associated Vertebral Fractures Following Discontinuation of Denosumab

地诺单抗停药后,骨质疏松性椎体骨折患者与反弹相关性椎体骨折患者在治疗管理上的异同

Anastasilakis, Athanasios D; Makras, Polyzois; Paccou, Julien; Bisbinas, Ilias; Polyzos, Stergios A; Papapoulos, Socrates E

Prevalence of FRAX risk factors and the osteoporosis treatment gap among women ≥ 70 years of age in routine primary care across 8 countries in Europe

欧洲8个国家70岁及以上女性在常规初级保健中FRAX风险因素患病率及骨质疏松症治疗缺口情况

McCloskey, Eugene; Rathi, Jeetandera; Heijmans, Stephane; Blagden, Mark; Cortet, Bernard; Czerwinski, Edward; Hadji, Peyman; Payer, Juraj; Palmer, Kerry; Stad, Robert; O'Kelly, James; Papapoulos, Socrates

Bone fragility in patients affected by congenital diseases non skeletal in origin

先天性非骨骼疾病患者的骨骼脆弱性

Masi, L; Ferrari, S; Javaid, M K; Papapoulos, S; Pierroz, D D; Brandi, M L

Increased Bone Resorption during Lactation in Pycnodysostosis

致密性骨质疏松症患者哺乳期间骨吸收增加

Ineke D C Jansen, Socrates E Papapoulos, Nathalie Bravenboer, Teun J de Vries, Natasha M Appelman-Dijkstra

ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis

ACTIVExtend:绝经后骨质疏松症患者在接受 18 个月阿巴洛帕肽或安慰剂治疗后,再接受 24 个月阿仑膦酸钠治疗

Bone, Henry G; Cosman, Felicia; Miller, Paul D; Williams, Gregory C; Hattersley, Gary; Hu, Ming-Yi; Fitzpatrick, Lorraine A; Mitlak, Bruce; Papapoulos, Socrates; Rizzoli, René; Dore, Robin K; Bilezikian, John P; Saag, Kenneth G